Accuray reported $81.01M in Cash and Equivalent for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Accuray ARAY:US USD 81.01M 7.73M
Angiodynamics ANGO:US USD 29.86M 5.29M
Atricure ATRC:US USD 122.64M 68.09M
Cardiovascular Systems CSII:US USD 62.85M 3.57M
Cryolife CRY:US USD 37.57M 2.81M
Edwards Lifesciences EW:US USD 1.25B 49.7M
Hologic HOLX:US USD 2.34B 35.8M
Inogen INGN:US USD 209.63M 13.99M
Mesa Laboratories MLAB:US USD 32.38M 11.37M
Orthofix International OFIX:US USD 51.66M 7.88M
Surmodics SRDX:US USD 19M 1.08M
Tandem Diabetes Care TNDM:US USD 123.79M 8.82M